Last reviewed · How we verify
NCT04945005: PLACE
Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation Registry
trial testing Transesophageal guidance of lead implantation in Tricuspid Valve Insufficiency in 124 participants. Completed in 31 December 2020.
31 December 2020
Quick facts
| Lead sponsor | LMU Klinikum |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 124 |
| Start date | 1 November 2019 |
| Primary completion | 31 December 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Transesophageal guidance of lead implantation
Conditions studied
- Tricuspid Valve Insufficiency — all drugs for Tricuspid Valve Insufficiency →
- Pacemaker Complication — all drugs for Pacemaker Complication →
- Echocardiography, Transesophageal — all drugs for Echocardiography, Transesophageal →
Sponsor
LMU Klinikum — full company profile →
Who can join
18 and older, any sex, with Tricuspid Valve Insufficiency or Pacemaker Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Registry for patients undergoing pacemaker/ICD implantation including a transtricuspid lead with and without intraprocedural transesophageal echocardiography to evaluate risk factors for lead induced tricuspid regurgitation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04945005
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tricuspid Valve Insufficiency
Currently open trials in the same condition.
- NCT06235385 — European Association of Cardiovascular Imaging Multiple and Mixed Valvular Disease Study · recruiting
- NCT06196684 — Early Safety and Clinical Efficacy of Mitral Allograft in Tricuspid Surgery · active not recruiting
- NCT04482062 — TRISCEND II Pivotal Trial · NA · active not recruiting
- NCT04735003 — Transcatheter Interventions for Tricuspid Insufficiency in Italy · recruiting
- NCT04614402 — Transcatheter Repair of Tricuspid Regurgitation With Edwards PASCAL Transcatheter Valve Repair System · active not recruiting
Other LMU Klinikum trials
Trials by the same sponsor.
- NCT07072676 — The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Train · NA · enrolling by invitation
- NCT07159607 — Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR) · recruiting
- NCT06600165 — Intraoperative Confocal Laser Scanning Microscopy With Use of AI for Optimized Surgical Excision of Basal Cell Carcinoma · recruiting
- NCT07460531 — Assessment of Physical Activity and Cardiovascular Outcomes in Patients With Chronic Heart Failure · recruiting
- NCT06605612 — Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04945005 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by LMU Klinikum
- Last refreshed: 30 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04945005.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing